Prexton Acquired by Lundbeck for up to €905m.
Oss, The Netherlands & Dublin, Ireland. 16 March 2018. H. Lundbeck A/S (Lundbeck) and Seroba’s Investee Company, Prexton Therapeutics BV (Prexton), today announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under the terms of the agreement, Lundbeck will pay EUR 100 million upfront plus EUR 805 million in development and …
